The decline of pneumococcal resistance after cessation of mass antibiotic distributions for trachoma.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 20649409.
- Also identified by DOI 10.1086/655697.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
After 6 biannual mass distributions of oral azithromycin for trachoma in Ethiopian communities, 76.8% (95% confidence interval [CI], 66.3%-85.1%) of nasopharyngeal Streptococcus pneumoniae isolates from children aged 1-5 years were resistant to macrolides. Twelve and 24 months after the last azithromycin treatment, resistance decreased to 30.6% (95% CI, 18.8%-40.4%; P <.001 ) and 20.8% (95% CI, 12.7%-30.7%; P < .001), respectively. Macrolide resistance decreases after antibiotic pressure is removed.
Medical subject headings
- Anti-Bacterial Agents
- Pneumococcal Infections
- Streptococcus pneumoniae
- Trachoma